DexCom: Delivering Consistent Growth
Summary
DexCom focuses on continuous glucose monitoring systems, with a strong market position and global reach. Q1 results show...
DexCom focuses on continuous glucose monitoring systems, with a strong market position and global reach. Q1 results showed 13% revenue growth, beating expectations, though earnings were slightly below consensus. Analysts remain bullish, with most issuing Buy ratings and price targets ranging from $87 to $110 per share.
Related Articles
DEXCOM ALERT: Bragar Eagel & Squire, P.C. is Investigating DexCom, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
DXCM
NegativeYouTube TV, NBCUniversal warn of impending carriage dispute that could lead to network blackout
CMCSA
NegativePRIVACY ALERT: PNC Financial Services Under Investigation for Data Breach of 740,000 Customer Records
PNC
Negative